tiprankstipranks
Trending News
More News >
PremiumCompany AnnouncementsRapport Therapeutics Reports Q1 2025 Financial Results
2M ago
Premium
Ratings
Optimistic Buy Rating for Rapport Therapeutics Driven by Promising RAP-219 Developments
2M ago
Premium
Ratings
Promising Clinical Developments and Strategic Initiatives Drive Buy Rating for Rapport Therapeutics, Inc.
2M ago
Rapport Therapeutics to present data at 2025 AAN meeting
PremiumThe FlyRapport Therapeutics to present data at 2025 AAN meeting
3M ago
Premium
Ratings
Buy Rating Affirmed for Rapport Therapeutics Amid Promising RAP-219 Trials and Strong Financial Position
4M ago
Premium
Company Announcements
Rapport Therapeutics Reports 2024 Financial Results and Progress
4M ago
PremiumCompany AnnouncementsRapport Therapeutics Appoints New CMO Amid Phase 2a Updates
4M ago
Rapport Therapeutics appoints Sevigny as Chief Medical Officer
Premium
The Fly
Rapport Therapeutics appoints Sevigny as Chief Medical Officer
4M ago
Premium
Company Announcements
Rapport Therapeutics’ Promising Trial Results and Leadership Change
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100